ELBERT AUSTIN THAMES, M.D.

Plain English
This study looked at the heart-related side effects of different therapies for advanced prostate cancer. Researchers found that a combination treatment involving androgen deprivation therapy, docetaxel, and abiraterone caused a higher risk of high blood pressure and irregular heartbeats compared to other treatments. Specifically, the risk of hypertension was 185% higher, and the risk of arrhythmias was 101% higher with the combination therapy. This is important because it highlights the potential heart risks associated with these therapies, helping doctors make safer treatment choices for their patients. Who this helps: This information benefits patients with advanced prostate cancer and their doctors.

Plain English
This study focused on how a specific protein, KHSRP, affects a type of RNA that is important for nerve growth called prenyl-Cdc42 mRNA. The researchers found that when nerves encounter growth-inhibiting signals, KHSRP increases and causes this RNA to break down more rapidly, which slows down nerve regeneration. Interestingly, when the RNA was removed from the axons of mice, the regeneration of their nerves sped up significantly. Who this helps: This helps patients with nerve injuries by potentially leading to new treatments that enhance nerve regeneration.

Plain English
This study looked at how a protein called KHSRP affects the levels of a specific mRNA needed for nerve growth, known as Prenyl-Cdc42, in nerve cells. The researchers found that higher levels of KHSRP slow down the amount of Prenyl-Cdc42 mRNA, which in turn slows nerve regeneration. In tests with mice lacking KHSRP, there was a significant increase in Prenyl-Cdc42 levels and improved nerve regeneration, showing this mechanism could be important for recovery after nerve injuries. Who this helps: This helps patients recovering from nerve injuries.

Plain English
This study investigated how a protein called KHSRP affects the ability of damaged nerve fibers to regenerate. Researchers found that after nerve injury, levels of KHSRP remain high, which slows down the growth of nerves. By targeting KHSRP, they showed that reducing its levels can speed up nerve healing, suggesting that there’s a connection between KHSRP and another protein, REG3A, that helps regulate nerve growth. Who this helps: This helps patients recovering from nerve injuries.

Plain English
This study investigated how a protein called G3BP1 behaves in nerve cells after injury and how its modification through a process called acetylation can speed up nerve healing. Researchers found that when G3BP1 is acetylated, specifically through a protein called ELP3, it helps increase protein production in the nerve, leading to faster recovery and better function after injury. The study showed that without ELP3, nerve cells grow fewer axons and have more trouble recovering from damage, highlighting the importance of G3BP1 in nerve repair. Who this helps: This helps patients with nerve injuries, providing insights for better recovery strategies.

Plain English
This study looked at whether health professional students could help lonely stroke survivors by making regular social phone calls. Out of 14 lonely stroke survivors who participated, 93% completed all the calls and surveys, and they reported feeling a mix of emotional challenges but also enjoyment from the conversations. This matters because it highlights a potential way to help reduce social isolation in stroke survivors, which is often overlooked. Who this helps: Patients who have survived a stroke.

Plain English
This study looked at a rare heart problem caused by Fabry's disease, which can lead to heart and kidney issues. It involved a 57-year-old woman who was evaluated for a kidney transplant and found to have severe thickening of the heart muscle. Tests confirmed a deficiency of specific enzymes and showed abnormal cell structures, helping to diagnose Fabry's disease accurately. This is important because it highlights the need for careful testing to identify the condition, which can be easily mistaken for other diseases. Who this helps: Patients with Fabry disease and their doctors.

Plain English
This study looked at how the protein KHSRP affects the healing process of injured nerves. Researchers found that after a nerve injury, the levels of KHSRP in the nerve axons rise quickly and stay elevated for up to 28 days, which leads to the destruction of other important mRNAs needed for nerve growth. In tests with mice that did not produce KHSRP, nerve regeneration was faster, suggesting that KHSRP hampers recovery. Who this helps: This helps patients recovering from nerve injuries.

Plain English
This study looked at how nerve cells manage the movement and translation of their genetic material, mRNA, along their long axons. Researchers found that specific groups of mRNAs, called RNA regulons, play a key role in vital processes like axon growth, repair after injury, and overall cell function. Understanding these processes is important for developing new strategies to treat nerve injuries and disorders. Who this helps: This helps patients with nerve damage and conditions affecting nerve function.

Plain English
This study looked at two specific microRNAs, miR-21 and miR-199a-3p, to see how they affect the growth of nerve fibers (axons) in response to injury. Researchers found that miR-21 promotes axon growth, while miR-199a-3p inhibits it; for example, when miR-21 levels were increased, neuron protein synthesis went up, and when miR-199a-3p levels rose, protein synthesis decreased. Understanding how these microRNAs influence nerve repair is important because it could lead to new treatments for nerve injuries and conditions like spinal cord injuries. Who this helps: This helps patients with nerve injuries, as well as doctors seeking to improve recovery strategies.

Plain English
This study looked at how to speed up the healing of damaged nerves in the peripheral nervous system by focusing on a protein called G3BP1. Researchers found that when a specific enzyme (CK2α) is activated after nerve injury, it helps break down G3BP1 granules, allowing important messages (mRNAs) to be released that support nerve growth. Specifically, this mechanism boosts the growth of nerves by about 50% more than if CK2α is not activated. Who this helps: This research benefits patients with nerve injuries, promoting faster recovery and improved outcomes.

Plain English
This study examined how a protein called HuD affects the movement of specific mRNA into nerve cell axons, which is important for nerve growth. The researchers found that HuD binds more strongly to neuritin mRNA than to another types of mRNA, meaning it can block neuritin from getting to the axons unless HuD is in lower amounts. Specifically, when there is less HuD present, the neuritin mRNA can better localize in the axons, suggesting that the balance of these molecules influences nerve development. Who this helps: Patients with nerve injuries or disorders affecting nerve growth.

Plain English
This study looked at how a natural extract from the Vernonia amygdalina plant affects triple-negative breast cancer (TNBC) cells and tumors. Researchers found that treating TNBC cells with this extract before chemotherapy significantly reduced tumor size, especially in mice with MDA-MB-468 tumors, showing a notable decrease in tumor volume. This is important because TNBC is hard to treat, and finding effective combinations like this could improve outcomes for patients. Who this helps: This research benefits patients with triple-negative breast cancer and their doctors by offering new treatment options.

Plain English
This study looked at how African American women with a type of breast cancer called triple negative breast cancer may respond better to a treatment that uses nitric oxide to trigger cell death in cancer cells. The researchers found that when they treated these African American cancer cells with nitric oxide, there was significant cell death, with high levels of specific indicators of this process like TUNEL-positive cells and active caspase-3. This is important because it suggests that understanding the differences in cancer biology between ethnic groups could lead to more effective, tailored treatments. Who this helps: This helps African American patients with triple negative breast cancer.

Plain English
This study looked at severe bleeding after childbirth (called postpartum hemorrhage) in two different time periods: 2000-2004 and 2005-2008. Researchers found that while the main cause of this bleeding remained the same, more women in the later period had higher body mass indexes and received medication called misoprostol and platelets to manage the bleeding. The use of these treatments increased significantly, but overall outcomes for patients did not change. Who this helps: This research benefits doctors and healthcare providers managing postpartum hemorrhage in women.

Plain English
This study looked at the potential complications related to wounds and bleeding in women who received blood-thinning medication after cesarean deliveries compared to those who did not. Researchers found that 30% of the women on anticoagulation had wound complications, compared to only 8% in the other group, indicating a significantly higher risk (p<0.001). However, there was no difference in overall bleeding complications between the two groups. Who this helps: This information is crucial for doctors and healthcare providers in managing the care of women who have had cesarean deliveries and are at risk for blood clots.

Plain English
This study looked at how effective a new device is for detecting von Willebrand disease in women who experience heavy menstrual bleeding (menorrhagia). Out of 108 women with menorrhagia, 28 had abnormal test results, with 7 showing signs of von Willebrand disease, while in a comparison group of 100 women without the condition, 18 had abnormal results with only 2 suggesting von Willebrand disease. This matters because identifying von Willebrand disease can lead to better treatment for women suffering from heavy menstrual bleeding and improve their quality of life. Who this helps: This helps women with menorrhagia and healthcare providers.